PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-09-09

Date Title Company
09-Sep-2025 UK Clinical Research: A Professional Awareness Update – 16 September, London CCRA
09-Sep-2025 Real-world evidence supports clinical effectiveness of neffy®/EURneffy® in U.S. patients experiencing anaphylaxis ALK
09-Sep-2025 Eckert & Ziegler: Berenberg Starts Coverage with a “Buy” Recommendation and a Price Target of € 24 – Price Potential 47% Eckert & Ziegler SE
09-Sep-2025 Medical Care Technologies Inc. (OTC PINK:MDCE) Projects Debt-Free Status by Year-End Driven by Strong Subsidiary Growth ACCESS Newswire
09-Sep-2025 Senzime welcomes new Japanese guidelines on neuromuscular monitoring Senzime
09-Sep-2025 Ankle & Foot Centers of America Opens New East Cobb Location ACCESS Newswire
09-Sep-2025 SpendMend Unveils Trulla Analytics 2.0: Analytics That Take Action(TM) ACCESS Newswire
09-Sep-2025 IGC Pharma, Inc. Receives Third Award from the NIA for Excellence in Code Clarity, Reproducibility, and Usability for Alzheimer's Detection ACCESS Newswire
09-Sep-2025 Michael Castanon Nominated for Executive of the Year 2025 in Southern California ACCESS Newswire
09-Sep-2025 Phase 1 Equity Announces It's Seventh Practice Addition Of The Year, Bringing On A Multi-Doctor Orthodontic Practice Located in New Jersey ACCESS Newswire
09-Sep-2025 Alchemab Therapeutics initiates Phase 1 clinical trial of ATLX-1282 and announces Series A financing extension Alchemab Therapeutics
09-Sep-2025 Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery ACCESS Newswire
09-Sep-2025 Results from BIG D-FOOT study using STIMULAN® when treating DFO to be presented at EBJIS 2025 Biocomposites
09-Sep-2025 Pheon Therapeutics Bolsters Board of Directors with Oncology R&D Expert Dr. Samuel Blackman Pheon Therapeutics
09-Sep-2025 CONNECTA Therapeutics to Advance CTH120 into Phase II Pediatric Development for Fragile X Syndrome with EIC Accelerator Support CONNECTA Therapeutics
09-Sep-2025 DeuterOncology to Present Promising Phase I DO-2 MET Kinase Inhibitor Data at WCLC 2025 DeuterOncology
09-Sep-2025 NanoViricides to Present at the Life Science Executive Partnering (LSX) Congress in Boston on September 17, 2025 ACCESS Newswire
09-Sep-2025 1933 Industries Closes Repurchase and Cancellation of Convertible Debentures ACCESS Newswire
09-Sep-2025 Global Cannabidiol (CBD) Market to grow at 16% CAGR, driven by legalization & wellness trends 2029 MediTech-Insights
09-Sep-2025 Global Legal Marijuana Market to grow 20-25% CAGR, driven by legalization & rising demand 2029 MediTech-Insights